vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Katapult Holdings, Inc. (KPLT). Click either name above to swap in a different company.
Katapult Holdings, Inc. is the larger business by last-quarter revenue ($73.9M vs $44.9M, roughly 1.6× AbCellera Biologics Inc.). Katapult Holdings, Inc. runs the higher net margin — 26.8% vs -19.9%, a 46.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 17.3%). Katapult Holdings, Inc. produced more free cash flow last quarter ($-12.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 6.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.
ABCL vs KPLT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $73.9M |
| Net Profit | $-8.9M | $19.8M |
| Gross Margin | — | 15.6% |
| Operating Margin | -63.7% | -1.4% |
| Net Margin | -19.9% | 26.8% |
| Revenue YoY | 788.4% | 17.3% |
| Net Profit YoY | 73.9% | 307.3% |
| EPS (diluted) | $-0.03 | $3.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $73.9M | ||
| Q3 25 | $9.0M | $74.0M | ||
| Q2 25 | $17.1M | $71.9M | ||
| Q1 25 | $4.2M | $71.9M | ||
| Q4 24 | $5.0M | $63.0M | ||
| Q3 24 | $6.5M | $60.3M | ||
| Q2 24 | $7.3M | $58.9M | ||
| Q1 24 | $10.0M | $65.1M |
| Q4 25 | $-8.9M | $19.8M | ||
| Q3 25 | $-57.1M | $-4.9M | ||
| Q2 25 | $-34.7M | $-7.8M | ||
| Q1 25 | $-45.6M | $-5.7M | ||
| Q4 24 | — | $-9.6M | ||
| Q3 24 | $-51.1M | $-8.9M | ||
| Q2 24 | $-36.9M | $-6.9M | ||
| Q1 24 | $-40.6M | $-570.0K |
| Q4 25 | — | 15.6% | ||
| Q3 25 | — | 19.7% | ||
| Q2 25 | — | 15.5% | ||
| Q1 25 | — | 19.9% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 19.8% | ||
| Q2 24 | — | 16.9% | ||
| Q1 24 | — | 25.3% |
| Q4 25 | -63.7% | -1.4% | ||
| Q3 25 | -851.8% | 3.3% | ||
| Q2 25 | -290.2% | -2.0% | ||
| Q1 25 | -1479.6% | -0.7% | ||
| Q4 24 | — | -7.7% | ||
| Q3 24 | -1439.4% | -7.4% | ||
| Q2 24 | -1276.2% | -4.5% | ||
| Q1 24 | -551.5% | 5.8% |
| Q4 25 | -19.9% | 26.8% | ||
| Q3 25 | -637.8% | -6.7% | ||
| Q2 25 | -203.3% | -10.9% | ||
| Q1 25 | -1077.2% | -7.9% | ||
| Q4 24 | — | -15.2% | ||
| Q3 24 | -785.4% | -14.7% | ||
| Q2 24 | -504.3% | -11.7% | ||
| Q1 24 | -408.0% | -0.9% |
| Q4 25 | $-0.03 | $3.69 | ||
| Q3 25 | $-0.19 | $-0.94 | ||
| Q2 25 | $-0.12 | $-1.63 | ||
| Q1 25 | $-0.15 | $-1.23 | ||
| Q4 24 | — | $-2.17 | ||
| Q3 24 | $-0.17 | $-2.05 | ||
| Q2 24 | $-0.13 | $-1.61 | ||
| Q1 24 | $-0.14 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $-38.1M |
| Total Assets | $1.4B | $107.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $22.4M | ||
| Q3 25 | $83.2M | $3.4M | ||
| Q2 25 | $92.4M | $3.7M | ||
| Q1 25 | $159.3M | $6.0M | ||
| Q4 24 | $156.3M | $3.5M | ||
| Q3 24 | $126.6M | $25.9M | ||
| Q2 24 | $148.3M | $33.7M | ||
| Q1 24 | $123.6M | $31.2M |
| Q4 25 | $966.9M | $-38.1M | ||
| Q3 25 | $964.0M | $-58.4M | ||
| Q2 25 | $1.0B | $-54.1M | ||
| Q1 25 | $1.0B | $-51.7M | ||
| Q4 24 | $1.1B | $-46.8M | ||
| Q3 24 | $1.1B | $-40.3M | ||
| Q2 24 | $1.1B | $-32.9M | ||
| Q1 24 | $1.1B | $-27.5M |
| Q4 25 | $1.4B | $107.9M | ||
| Q3 25 | $1.4B | $85.9M | ||
| Q2 25 | $1.4B | $90.6M | ||
| Q1 25 | $1.3B | $88.5M | ||
| Q4 24 | $1.4B | $93.2M | ||
| Q3 24 | $1.4B | $92.0M | ||
| Q2 24 | $1.4B | $106.6M | ||
| Q1 24 | $1.5B | $106.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-11.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $-12.0M |
| FCF MarginFCF / Revenue | -99.4% | -16.2% |
| Capex IntensityCapex / Revenue | 21.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -0.60× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-11.9M | ||
| Q3 25 | $-52.6M | $4.0M | ||
| Q2 25 | $-32.4M | $-6.6M | ||
| Q1 25 | $-11.6M | $3.4M | ||
| Q4 24 | $-108.6M | $-32.6M | ||
| Q3 24 | $-28.9M | $-5.4M | ||
| Q2 24 | $-30.0M | $-628.0K | ||
| Q1 24 | $-41.7M | $2.0M |
| Q4 25 | $-44.6M | $-12.0M | ||
| Q3 25 | $-61.5M | $4.0M | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | $3.4M | ||
| Q4 24 | $-187.0M | $-32.6M | ||
| Q3 24 | $-47.4M | $-5.4M | ||
| Q2 24 | $-50.1M | $-653.0K | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | -16.2% | ||
| Q3 25 | -687.0% | 5.4% | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | 4.7% | ||
| Q4 24 | -3702.8% | -51.8% | ||
| Q3 24 | -728.4% | -9.0% | ||
| Q2 24 | -683.8% | -1.1% | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | 0.0% | ||
| Q3 25 | 99.7% | 0.0% | ||
| Q2 25 | 78.2% | 0.0% | ||
| Q1 25 | 251.1% | 0.0% | ||
| Q4 24 | 1552.7% | 0.1% | ||
| Q3 24 | 284.6% | 0.0% | ||
| Q2 24 | 274.6% | 0.0% | ||
| Q1 24 | 242.5% | 0.0% |
| Q4 25 | — | -0.60× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
